Prins G S, Cecim M, Birch L, Wagner T E, Bartke A
Department of Obstetrics and Gynecology, Humana-Michael Reese Hospital, University of Illinois School of Medicine, Chicago 60616.
Endocrinology. 1992 Oct;131(4):2016-23. doi: 10.1210/endo.131.4.1396345.
Previous work has shown that expression of human (h) GH in transgenic mice is associated with significant age-related enlargement of seminal vesicles. To further explore this aberrant growth activity, we have characterized seminal vesicles from various GH transgenic lines and examined their androgen receptor (AR) content and distribution. Six groups of animals were initially studied: young adult (3-5 months) control mice, old (greater than 12 months) control mice, young adult hGH transgenic mice, old hGH transgenics, young adult bovine (b) GH transgenics, and old bGH transgenic mice. Young transgenic mice (hGH and bGH) possessed seminal vesicles with similar relative weights, DNA and protein contents, and AR levels as nontransgenic littermates. Histologically, the glands appeared similar. With aging, the hGH transgenic seminal vesicles exhibited massive stromal hyperplasia, whereas the glands from controls and bGH transgenic mice did not show this response. Seminal vesicles from old hGH mice presented with a marked increase in cell number (DNA content) and a marked decrease in cell size and/or glandular secretions (protein/DNA ratio) compared to those from old controls and young hGH transgenic mice. Tissue AR content was markedly reduced in old hyperplastic hGH seminal vesicles compared to that in seminal vesicles from young hGH transgenics, old controls, and old bGH transgenic mice. Immunohistochemistry indicated the absence of AR in the proliferating stromal cells, whereas acinar epithelial cells showed similar or moderately reduced AR staining intensity compared to control seminal vesicles. To examine whether the above results may be due to insertional mutagenesis rather than hGH itself, two additional GH transgenic lines were examined. Aged transgenic mice expressing bGH with an alternate promoter possessed seminal vesicle weights that were not different from those of old controls, whereas aged transgenic mice expressing an hGH. V gene (variant gene, placental origin) possessed significantly larger vesicles than the controls, which further suggests that vesicular hyperplasia is specifically related to hGH. To assess androgen responsiveness, aged control and hGH transgenic mice were castrated and examined after 15 days. While control seminal vesicles significantly decreased in size, glands from transgenic mice did not. Regressive changes were observed in the remaining epithelium of hGH transgenic mice; however, stromal tissue exhibited no response to androgen withdrawal. The present results suggest that the aging-associated seminal vesicle hyperplasia in hGH transgenic mice is a result of a massive increase in stromal tissue that is low or devoid of AR, suggesting a loss of direct androgen regulation.(ABSTRACT TRUNCATED AT 400 WORDS)
先前的研究表明,人(h)生长激素在转基因小鼠中的表达与精囊显著的年龄相关性增大有关。为了进一步探究这种异常的生长活性,我们对来自不同生长激素转基因品系的精囊进行了表征,并检测了它们的雄激素受体(AR)含量和分布。最初研究了六组动物:年轻成年(3 - 5个月)对照小鼠、老年(大于12个月)对照小鼠、年轻成年hGH转基因小鼠、老年hGH转基因小鼠、年轻成年牛(b)GH转基因小鼠和老年bGH转基因小鼠。年轻的转基因小鼠(hGH和bGH)的精囊与非转基因同窝小鼠相比,具有相似的相对重量、DNA和蛋白质含量以及AR水平。从组织学上看,腺体看起来相似。随着年龄增长,hGH转基因精囊出现大量间质增生,而对照和bGH转基因小鼠的腺体未表现出这种反应。与老年对照和年轻hGH转基因小鼠的精囊相比,老年hGH小鼠的精囊细胞数量显著增加(DNA含量),细胞大小和/或腺体分泌物显著减少(蛋白质/DNA比率)。与年轻hGH转基因小鼠、老年对照和老年bGH转基因小鼠的精囊相比,老年增生性hGH精囊的组织AR含量显著降低。免疫组织化学表明,增殖的间质细胞中不存在AR,而腺泡上皮细胞与对照精囊相比,AR染色强度相似或略有降低。为了检查上述结果是否可能是由于插入诱变而非hGH本身导致的,我们检测了另外两个生长激素转基因品系。表达带有替代启动子的bGH的老年转基因小鼠的精囊重量与老年对照小鼠的精囊重量没有差异,而表达hGH V基因(变异基因,胎盘来源)的老年转基因小鼠的精囊明显大于对照小鼠的精囊,这进一步表明精囊增生与hGH特异性相关。为了评估雄激素反应性,对老年对照和hGH转基因小鼠进行去势,并在15天后进行检查。虽然对照精囊大小显著减小,但转基因小鼠的腺体没有。在hGH转基因小鼠剩余的上皮中观察到退行性变化;然而,间质组织对雄激素去除没有反应。目前的结果表明,hGH转基因小鼠中与年龄相关的精囊增生是间质组织大量增加的结果,该间质组织中AR含量低或缺乏AR,这表明直接雄激素调节丧失。(摘要截短至400字)